FST and malignant colon neoplasm: The significant correlations for serum and tissue activin-A and follistatin with the types and sizes of neoplastic lesions provide further support to the notion that these proteins could be sensitive biochemical markers and/or potential molecular targets for the diagnosis and/or treatment of colon cancer.